Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The Relative Contributions of NIH and Private Sector Funding to the Approval of New Biopharmaceuticals

Therapeutic Innovation & Regulatory Science(2022)10.1007/s43441-022-00451-8Source: DataRank Database

The Relative Contributions of NIH and Private Sector Funding to the Approval of New Biopharmaceuticals is a research paper published in Therapeutic Innovation & Regulatory Science (2022). On theSindex it has a DataRank of 0. It has been cited 30 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access30 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)OA: hybridTopics (10)IDs (PubMed, PMC)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Harry P. Bowen,Robert Popovian ORCID,Daniel Gassull,Augustine Zhang,Joe Hammang

Live enrichment

PubMed:36057746 PMC:PMC9440766

GlaxoSmithKline

Pfizer

Amgen

Pharmaceutical Research and Manufacturers of America Foundation

Sanofi

Biotechnology Innovation Organization

Novartis

hybridLicense: cc-by

publisherhttps://link.springer.com/content/pdf/10.1007/s43441-022-00451-8.pdf

publisherhttps://link.springer.com/article/10.1007/s43441-022-00451-8/fulltext.html

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9440766

Europe_PMChttps://europepmc.org/articles/PMC9440766

Europe_PMChttps://europepmc.org/articles/PMC9440766?pdf=render

MeSH Terms

HumansBiological ProductsPharmaceutical PreparationsUnited States Food and Drug AdministrationPrivate SectorUnited States

Keywords

Fda ApprovalNih FundingMarch-in RightsBayh–dole Act

The Relative Contributions of NIH and Private Sector Funding to the Approval of New Biopharmaceuticals

FAIR Checklist

Authors (6)

Funding (7 grants)

Open Access

Topics

Annotations (Europe PMC)